Bladder Papillary Urothelial Neoplasm C1511197
A bladder tumor with papillary growth patterns, ranging from low-grade lesions with good prognosis to higher-risk neoplasms.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(oncologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Painless hematuria
(urinary)Urinary frequency
(urinary)Dysuria
(urinary)Flank pain
(urinary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Transurethral resection of bladder tumor
Endoscopic surgical procedure using a resectoscope inserted through the urethra to remove visible bladder tumors and obtain tissue samples for pathological examination and staging.
Fluorescence cystoscopy
Enhanced visualization technique using photosensitizing agents and blue light during cystoscopy to improve detection of flat or subtle lesions that may be missed with standard white-light cystoscopy.
Additional treatment options
Intravesical BCG immunotherapy
Installation of Bacillus Calmette-Guérin live attenuated vaccine directly into the bladder via catheter to stimulate local immune response and reduce tumor recurrence in high-risk non-muscle-invasive bladder cancer.
medicationRoutine cystoscopic surveillance
Regular follow-up cystoscopy examinations at scheduled intervals to detect tumor recurrence early, with frequency based on initial tumor grade and risk classification.
monitoringSmoking cessation
Comprehensive tobacco cessation program addressing smoking as the primary modifiable risk factor for bladder cancer development and recurrence, using counseling, nicotine replacement, and pharmacotherapy.
lifestyleMedication Comparisons
Compare medications used to treat Bladder Papillary Urothelial Neoplasm C1511197. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy